1. Korbecki, Jan, Kojder, Klaudyna, Kapczuk, Patrycja, Chlubek, Dariusz, Baranowska-Bosiacka, Irena. 2021. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature. In International journal of molecular sciences, 22, . doi:10.3390/ijms22020843. https://pubmed.ncbi.nlm.nih.gov/33467722/
2. Gullotta, Giorgia Serena, De Feo, Donatella, Friebel, Ekaterina, Martino, Gianvito, Bacigaluppi, Marco. 2023. Age-induced alterations of granulopoiesis generate atypical neutrophils that aggravate stroke pathology. In Nature immunology, 24, 925-940. doi:10.1038/s41590-023-01505-1. https://pubmed.ncbi.nlm.nih.gov/37188941/
3. Xin, Hua, Cao, Yu, Shao, Ming-Liang, Jia, Lin-Lin, Wang, Wei-Qun. 2018. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion. In International urology and nephrology, 50, 861-868. doi:10.1007/s11255-018-1818-9. https://pubmed.ncbi.nlm.nih.gov/29524043/
4. Cheng, Yao, Yang, Xinyan, Liang, Lichun, Zhang, Chunbin, Wang, Weiqun. 2023. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner. In BMC cancer, 23, 1162. doi:10.1186/s12885-023-11655-y. https://pubmed.ncbi.nlm.nih.gov/38031087/
5. Kusuyama, Joji, Komorizono, Anna, Bandow, Kenjiro, Ohnishi, Tomokazu, Matsuguchi, Tetsuya. 2016. CXCL3 positively regulates adipogenic differentiation. In Journal of lipid research, 57, 1806-1820. doi:10.1194/jlr.M067207. https://pubmed.ncbi.nlm.nih.gov/27512010/
6. Lv, Qi-Yuan, Zou, Hai-Zhou, Xu, Yu-Yan, Su, Meng, Zou, Chang-Lin. . Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses. In Bioengineered, 12, 3711-3725. doi:10.1080/21655979.2021.1952772. https://pubmed.ncbi.nlm.nih.gov/34269159/
智鼠故事 
